Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report

The arrival of subsequent generations of tyrosine-kinase inhibitors (TKIs) has significantly broaden the EGFR-mutated lung cancer therapeutic landscape. Results from the FLAURA clinical trial have pushed osimertinib to the first-line treatment for patients with advanced-stage disease, showing outsta...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarrán, Víctor, Pozas, Javier, José Soto, Juan, Esteban, Jorge, Corral, Elena, Lage, Yolanda, Gajate, Pablo, Garrido, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272655/
https://www.ncbi.nlm.nih.gov/pubmed/34306781
http://dx.doi.org/10.1155/2021/5526809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272655/
https://www.ncbi.nlm.nih.gov/pubmed/34306781
http://dx.doi.org/10.1155/2021/5526809

Ejemplares similares